Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from AddLife AB ( ($SE:ALIF.B) ) is now available.
AddLife AB has acquired Opitek International ApS, a Danish MedTech company specializing in patient positioning solutions, to enhance its Mediplast division. This strategic acquisition is expected to bolster AddLife’s presence in the orthopedic segment by leveraging Opitek’s innovative product portfolio and established customer relationships. The move aligns with AddLife’s growth strategy, aiming to expand its own brands and accelerate market reach, potentially leading to long-term profitable growth.
The most recent analyst rating on ($SE:ALIF.B) stock is a Hold with a SEK200.00 price target. To see the full list of analyst forecasts on AddLife AB stock, see the SE:ALIF.B Stock Forecast page.
More about AddLife AB
AddLife AB is an independent partner in the Life Science industry, offering high-quality products, services, and advice to both private and public sectors across Europe. With more than 2,300 employees and net sales exceeding SEK 10 billion, AddLife operates through approximately 85 subsidiaries. Its shares are listed on Nasdaq Stockholm. Mediplast, part of the AddLife Group, is a MedTech company based in Malmö, Sweden, known for producing and distributing a wide range of medical solutions, serving hospitals and healthcare providers globally.
YTD Price Performance: 38.21%
Average Trading Volume: 80,974
Technical Sentiment Signal: Strong Buy
Current Market Cap: SEK23.05B
Learn more about ALIF.B stock on TipRanks’ Stock Analysis page.